Search Prime Grants

U01CA232563

Cooperative Agreement

Overview

Grant Description
Cassette exons in neoplastic pro-B-cells: implications for immunotherapy.
Awardee
The Children's Hospital Of Philadelphia
Funding Goals
TO PROVIDE SUPPORT FOR INITIATIVES FUNDED UNDER THE 21ST CENTURY CURES ACT TO SUPPORT CANCER RESEARCH, SUCH AS THE DEVELOPMENT OF CANCER VACCINES, THE DEVELOPMENT OF MORE SENSITIVE DIAGNOSTIC TESTS FOR CANCER, IMMUNOTHERAPY AND THE DEVELOPMENT OF COMBINATION THERAPIES, AND RESEARCH THAT HAS THE POTENTIAL TO TRANSFORM THE SCIENTIFIC FIELD, THAT HAS INHERENTLY HIGHER RISK, AND THAT SEEKS TO ADDRESS MAJOR CHALLENGES RELATED TO CANCER.
Grant Program (CFDA)
93.353 - 21st Century Cures Act - Beau Biden Cancer Moonshot
Awarding / Funding Agency
National Cancer Institute (NCI) [HHS - NIH]
Place of Performance
Philadelphia, Pennsylvania 191462305 United States
Geographic Scope
Single Zip Code
Related Opportunity
Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01) (RFA-CA-17-051)
Analysis Notes
Amendment Since initial award the End Date has been extended from 06/30/23 to 06/30/24 and the total obligations have increased 21% from $2,931,750 to $3,537,446.
The Children's Hospital Of Philadelphia was awarded Cassette exons in neoplastic pro-B-cells: implications for immunotherapy Cooperative Agreement U01CA232563 worth $3,537,446 from National Cancer Institute in September 2018 with work to be completed primarily in Philadelphia Pennsylvania United States. The grant has a duration of 5 years 9 months and was awarded through assistance program 93.353 21st Century Cures Act - Beau Biden Cancer Moonshot. The Cooperative Agreement was awarded through grant opportunity Pediatric Immunotherapy Translational Science Network (PI-TSN)(U01).

Status
(Complete)

Last Modified 10/21/24

Period of Performance
9/14/18
Start Date
6/30/24
End Date
100% Complete

Funding Split
$3.5M
Federal Obligation
$0.0
Non-Federal Obligation
$3.5M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U01CA232563

Subgrant Awards

Disclosed subgrants for U01CA232563

Transaction History

Modifications to U01CA232563

Additional Detail

Award ID FAIN
U01CA232563
SAI Number
U01CA232563-2407027103
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
G7MQPLSUX1L4
Awardee CAGE
0GXU0
Performance District
PA-03
Senators
Robert Casey
John Fetterman

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) Health research and training Grants, subsidies, and contributions (41.0) $6,469,208 100%
Modified: 10/21/24